Privia Health (PRVA) Cash & Current Investments (2020 - 2026)

Privia Health has reported Cash & Current Investments for 7 years, with the latest figure at $419.5 million in Q1 2026.

• For the quarter ending Q1 2026, Cash & Current Investments fell 10.61% year-over-year to $419.5 million; the trailing twelve-month figure through Mar 2026 stood at $419.5 million (down 10.61% YoY), and the FY2025 full-year result was $479.7 million, down 2.33% from the prior year.
• Cash & Current Investments for Q1 2026 stood at $419.5 million, down from $479.7 million in the prior quarter.
• The five-year high for Cash & Current Investments was $491.1 million in Q4 2024, with the low at $292.2 million in Q2 2022.
• Average Cash & Current Investments over 5 years is $380.8 million, with a median of $387.4 million recorded in 2024.
• Peak annual rise in Cash & Current Investments reached 285.57% in 2022, while the deepest fall reached 12.49% in 2022.
• Tracing PRVA's Cash & Current Investments over 5 years: stood at $348.0 million in 2022, then increased by 11.93% to $389.5 million in 2023, then increased by 26.09% to $491.1 million in 2024, then dropped by 2.33% to $479.7 million in 2025, then declined by 12.54% to $419.5 million in 2026.
• The last three Cash & Current Investments figures came in at $419.5 million (Q1 2026), $479.7 million (Q4 2025), and $441.4 million (Q3 2025), per Business Quant data.

Peer Comparison